ATR and cancer: Cancer cells that have acquired defects in certain aspects of the DDR, such as p53-dependent cell cycle arrest at G1/S and G2/M, may be more dependent on ATR to resolve DNA damage before a cell cycle transition generates potentially lethal mutations and mitotic catastrophe [1,4,5].